Hide Board Information

Show Board Information

Foghorn Therapeutics Inc. FHTX

Board Mod: Add me as mod

Asst Mods:

Last Post: 12/22/2021 6:32:04 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Foghorn Therapeutics Inc. (NASDAQ: FHTX) Stock Message Board

1. FHTX Company Profile

    

2. FHTX Time & Sales

    

3. FHTX Recent News

    

4. FHTX Filings

    

5. FHTX Financials

    

6. FHTX Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Foghorn Therapeutics Inc. FHTX

Recent Articles

• Exploring Innovative Strategies in Blood Cancer Treatment
• Creative Brands Expands Portfolio with C.R. Gibson Acquisition
• Antlara Dental Launches Innovative Timeless White Shade
• Rejuva Fresh® Introduces Advanced REVIVO™ Laser Technology
• Healthcare Leaders Aim to Navigate Changes with Clinical Data Insights
• Innovative Portable Scale Enhances Care for Mobility-Restricted
• Franchise Equity Partners Expands with 7 Brew Coffee Investment
• Investigation into Potential Violations Affecting Shareholders
• August 2025 Traffic Insights from VINCI Autoroutes and Airports
• Zapp EV Unveils Business Strategy and Meeting Plans
• Exploring Financial Insights for Transgene in 2025
• Photonic Inc. Leaders to Influence Future of Quantum Tech
• Assystem's Strong Growth in First Half of 2025 Financials
• Forecasting Growth in Global HR Tech Consulting Sector
• Corteva Stock Growth: Your Potential Earnings in 5 Years
• Insights into Sogeclair's Voting Rights and Share Structure
• Assystem Sees Growth in 2025 with Strong Revenue Results
• APA Infrastructure Limited Announces Tender Offer Pricing Details
• Blink Charging Achieves Prestigious EV Charger Certification
• Sion Power Elevates Lithium-Metal Anode Technology with Innovation
• Oscar Health Increases Convertible Note Offering for AI Growth
• Revolutionizing Venipuncture: An Innovative Approach to Blood Draws
• Exciting Partnerships Propel Affirm Holdings Future Growth
• Kristina Janssens Named Comerica’s Chief Risk Officer
• QuadReal Enhances Its Global Presence with Realstar Acquisition
• SonderMind's AI Notes Tool: Transforming Mental Health Care
• Navigating Risks: Internal Audit Strategies for 2025 and Beyond
• Cracker Barrel's Strategic Shift Amid Rebranding Challenges
• Examining Mergers: What Shareholders Should Know Today
• FactSet Research Systems Inc: Q4 Earnings Expectations Insider
• Experience History: Presidents Explored Through Their Fashion
• Brother USA Launches Innovative Inkjet Printers for All Users
• CIO Strategies for Sustainable Growth in an AI Era
• Unlocking Economic Potential: Strategies for a Unified Market
• Starbird Launches New Indian Hotbird Menu for Bold Flavors
• Cyber Enviro-Tech Spins Off Alvey Oil Field to Expand Focus
• Seeking Justice: Halper Sadeh Investigates DAY, HBI, SPNS Shareholders
• TOMI Environmental Solutions Welcomes Francesco Fragasso
• Enjoy Exclusive Uber One Benefits with TD Cardholder Offers
• Innovative Leadership Transition at Cyber A.I. Group, Inc.
• Class Action Filed for Fluor Corporation Investors: What Next?
• Webtoon Entertainment's Strategic Disney Partnership Boosts Stock
• The Remarkable Journey of Analog Devices Stock Over 15 Years
• Analysts Adjust Expectations for Dave & Buster's Performance
• Darden Restaurants Prepares for Earnings Report: Analyst Insights
• Mitchell Kitayama Exercises Significant Stock Options at Astrana Health
• Balkrishan Kalra's $578K Options Exercise at Genpact
• Phil Horlock's Major Stock Option Move at Blue Bird Corp
• Chief Financial Officer of Clearfield Invests in Company Shares
• New NIH Funded Clinical Trial Revolutionizes Shoulder Repair Methods